Liewei Wang Selected Research

Neoadjuvant Therapy

8/2022	Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer.
6/2022	Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.
1/2021	Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY).
10/2019	Comparison of 99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy.
12/2018	PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.
11/2018	ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.
1/2018	Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
1/2018	BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
12/2017	Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
1/2017	Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liewei Wang Research Topics

Disease

78	Neoplasms (Cancer) 04/2024 - 09/2008
75	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2005
21	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2015
14	Triple Negative Breast Neoplasms 04/2024 - 01/2017
14	Major Depressive Disorder (Major Depressive Disorders) 11/2022 - 03/2013
6	Drug-Related Side Effects and Adverse Reactions 02/2021 - 09/2003
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2015
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 06/2010
4	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2011
4	Stroke (Strokes) 01/2020 - 01/2011
3	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 06/2023
3	Circulating Neoplastic Cells 01/2023 - 08/2017
3	Inflammation (Inflammations) 01/2022 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2018
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021 - 01/2019
3	Myocardial Infarction 01/2020 - 01/2011
3	T-Cell Leukemia (Leukemia, T Cell) 01/2018 - 03/2012
3	Leukemia 09/2017 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 06/2011
3	Carcinogenesis 08/2011 - 03/2006
2	Osteoporosis 11/2022 - 10/2014
2	Obesity 01/2022 - 01/2019
2	Rheumatoid Arthritis 01/2022 - 01/2022
2	Thrombosis (Thrombus) 01/2021 - 01/2020
2	Multiple Myeloma 01/2021 - 06/2008
2	Hemorrhage 01/2020 - 01/2020
2	Pathologic Complete Response 01/2018 - 01/2017
2	Musculoskeletal Pain 03/2016 - 03/2012
2	Adenocarcinoma 02/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2012
19	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 06/2008
17	Aromatase InhibitorsIBA 10/2021 - 12/2005
15	Estrogens (Estrogen)FDA Link 05/2024 - 12/2005
15	Estrogen ReceptorsIBA 01/2024 - 04/2013
11	Gemcitabine FDA Link 12/2016 - 09/2008
10	Anastrozole (Arimidex)FDA LinkGeneric 05/2024 - 01/2010
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2011
10	Small Interfering RNA (siRNA)IBA 12/2016 - 11/2009
9	RNA (Ribonucleic Acid)IBA 04/2024 - 12/2014
9	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2017
7	Phenobarbital (Luminal)FDA Link 03/2024 - 01/2017
6	Estradiol (Delestrogen)FDA LinkGeneric 05/2024 - 01/2010
6	abirateroneIBA 01/2023 - 08/2017
6	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2015
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 03/2013
5	Abiraterone AcetateIBA 01/2023 - 08/2017
5	taxaneIBA 12/2022 - 09/2012
5	AnthracyclinesIBA 12/2022 - 12/2017
5	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2018
5	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2017
5	exemestane (Aromasin)FDA Link 01/2022 - 12/2016
5	Aromatase (CYP19)IBA 01/2020 - 12/2005
5	Selective Estrogen Receptor Modulators (SERM)IBA 08/2017 - 07/2013
5	CytidineIBA 02/2014 - 09/2008
4	Estrone FDA Link 05/2024 - 01/2010
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 08/2017
4	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 09/2011
4	enzalutamideIBA 01/2023 - 01/2015
4	GlucocorticoidsIBA 11/2022 - 01/2018
4	Tamoxifen FDA LinkGeneric 01/2021 - 07/2013
4	AndrogensIBA 01/2021 - 01/2015
4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2018
4	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2012
4	P-2 (P 2)IBA 10/2017 - 07/2013
3	LigandsIBA 01/2024 - 08/2017
3	Therapeutic UsesIBA 01/2023 - 09/2008
3	ChromatinIBA 01/2023 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 12/2022 - 01/2018
3	Long Noncoding RNAIBA 12/2021 - 12/2016
3	Docetaxel (Taxotere)FDA Link 01/2021 - 09/2012
3	EnzymesIBA 01/2019 - 12/2005
3	olaparibIBA 12/2018 - 01/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 01/2015
3	Messenger RNA (mRNA)IBA 11/2017 - 12/2014
3	2-mercaptopurineIBA 03/2014 - 09/2003
2	Monoclonal AntibodiesIBA 01/2022 - 12/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2022
2	Letrozole (Femara)FDA LinkGeneric 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 03/2012
2	Aurora Kinase AIBA 01/2021 - 01/2018
2	Cytochrome P-450 CYP2C19IBA 01/2021 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 12/2018
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2020
2	MethyltransferasesIBA 11/2019 - 01/2018
2	Nucleic AcidsIBA 03/2019 - 09/2008
2	Escitalopram FDA Link 01/2019 - 01/2019
2	Citalopram FDA LinkGeneric 01/2019 - 01/2019
2	Estrogen Receptor alphaIBA 01/2018 - 01/2017
2	HomocysteineIBA 01/2018 - 03/2014
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 09/2012
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2015 - 10/2015
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2015 - 07/2013

Therapy/Procedure

59	Therapeutics 04/2024 - 01/2010
38	Drug Therapy (Chemotherapy) 01/2023 - 09/2004
14	Castration 01/2023 - 08/2017
13	Neoadjuvant Therapy 08/2022 - 01/2010
4	Precision Medicine 02/2023 - 01/2015
3	Radiotherapy 01/2021 - 11/2010
2	Stents 01/2021 - 01/2020